| Literature DB >> 33387152 |
Bagher Larijani1, Peyvand Parhizkar Roudsari2, Mahdieh Hadavandkhani3, Sepideh Alavi-Moghadam3, Mostafa Rezaei-Tavirani4, Parisa Goodarzi5, Forough Azam Sayahpour6, Fereshteh Mohamadi-Jahani5, Babak Arjmand7,8.
Abstract
Psychiatric disorders such as schizophrenia can generate distress and disability along with heavy costs on individuals and health care systems. Different genetic and environmental factors play a pivotal role in the appearance of the mentioned disorders. Since the conventional treatment options for psychiatric disorders are suboptimal, investigators are trying to find novel strategies. Herein, stem cell therapies have been recommended as novel choices. In this context, the preclinical examination of stem cell-based therapies specifically using appropriate models can facilitate passing strong filters and serious examination to ensure proper quality and safety of them as a novel treatment approach. Animal models cannot be adequately helpful to follow pathophysiological features. Nowadays, stem cell-based models, particularly induced pluripotent stem cells reflected as suitable alternative models in this field. Accordingly, the importance of stem cell-based models, especially to experiment with the regenerative medicine outcomes for schizophrenia as one of the severe typing of psychiatric disorders, is addressed here.Entities:
Keywords: Disease models; Induced pluripotent stem cells; Psychiatric disorders; Regenerative medicines; Schizophrenia; Stem cell transplantation
Year: 2021 PMID: 33387152 DOI: 10.1007/s10561-020-09888-3
Source DB: PubMed Journal: Cell Tissue Bank ISSN: 1389-9333 Impact factor: 1.522